Biocon Ltd. (BIOCON) Share Price Near 52-Week Low as Stock Trades Around Rs 342.25

Biocon Share Price is trading at Rs 342.25, up 0.51% today, and remains near its 52-week low while the market capitalisation stands at Rs 55,491.09 crore. The latest Biocon Share Price move keeps Biocon Share Price in focus for traders watching Stocks in News and for investors tracking 52 Week Low Stocks in the Indian Stock Market. The verified market data confirms the price event, but it does not establish a company-specific catalyst for the latest Biocon Stock News.

For Biocon Share Price Today, the key point is that the stock is moving in a narrow band around Rs 342.25 after opening at Rs 341 and touching an intraday high of Rs 343.55 and low of Rs 341. The latest Biocon Share Price action is relevant because it places the stock close to a yearly low zone even after a modest gain from the previous close of Rs 340.5. Univest data therefore shows a share price that is under pressure on a broader time frame, even though the current intraday move is positive. Investors following Biocon Share Price Live will likely focus on support behaviour, market cap context and whether the next moves remain aligned with the wider price trend. This is also why Biocon Share Price Today is attracting attention in market updates.

Biocon Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 342.25
Previous Close	Rs 340.5
Today's Move	+Rs 1.75 (+0.51%)
Open	Rs 341
High	Rs 343.55
Low	Rs 341
Market Capitalisation	Rs 55,491.09 crore

Biocon Ltd. (BIOCON) traded at Rs 342.25 versus the previous close of Rs 340.5, a rise of 0.51%. The stock opened at Rs 341, reached a high of Rs 343.55, touched a low of Rs 341.

Biocon Share Price Today shows a mixed intraday picture. The stock last traded at Rs 342.25 versus the previous close of Rs 340.5, a gain of Rs 1.75 or 0.51%. The day open was Rs 341, the high was Rs 343.55 and the low was Rs 341, which suggests a tight range and limited directional follow-through so far. Biocon Share Price therefore remains close to the 52-week low even after a small rise, which keeps the stock on the radar in Stock Market Today coverage.

The current market capitalisation of Rs 55,491.09 crore places Biocon among larger names in Healthcare, but size does not by itself indicate quality or momentum. What matters for Biocon Share Price News is that the broader chart remains weak versus longer-term levels, while the intraday path is only modestly higher. The latest Biocon Share Price Update shows that the stock is still trading well below its 50 DMA of Rs 375.52 and its 200 DMA of Rs 397.25, so the medium-term price structure stays subdued. In practical terms, Biocon Share Price is still behaving like a stock in a support-rebuilding phase rather than a confirmed breakout phase, which is why traders continue to track the day range and the nearby low closely. That sets up the need for a deeper Biocon Technical Analysis view through price structure and trend context.

Biocon Ltd. (BIOCON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 55,491.09 crore
P/E Ratio	112.04x
P/B Ratio	1.63x
ROE	1.35%
ROCE	3.26%
EPS	Rs 3.04
Book Value Per Share	Rs 208.53
Dividend Yield	0.15%

Biocon Ltd. (BIOCON) fundamental metrics show P/E 112.04x, P/B 1.63x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.

Biocon Ltd. has a market capitalisation of Rs 55,491.09 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 112.04x, P/B at 1.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.67x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	112.04x
Benchmark Median P/E	26.67x
Benchmark Average P/E	38.92x
Benchmark P/E Range	0x to 616.89x
Company P/B Ratio	1.63x
Benchmark Median P/B	2.75x
Company ROE	1.35%
Benchmark Median ROE	11.33%
Company ROCE	3.26%
Benchmark Median ROCE	13.25%
Company Market Capitalisation	Rs 55,491.09 crore
Benchmark Median Market Cap	Rs 768.75 crore

Biocon Ltd. (BIOCON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Biocon Ltd. (BIOCON) has a P/E ratio of 112.04x, which is above the benchmark median of 26.67x, a difference of +320.1%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.33%, a difference of -88.08%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.25%, a difference of -75.4%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Abbott India Ltd.	ABBOTINDIA	54,909.79	34.01	10.61	34.67	46.72
Alkem Laboratories Ltd.	ALKEM	59,722.72	27.68	4.17	18.29	21.28
Gland Pharma Ltd.	GLAND	49,952.91	44.25	4.7	10.56	14.96
Glenmark Pharmaceuticals Ltd.	GLENMARK	62,339.2	34.67	5.69	14.1	20.35
Ipca Laboratories Ltd.	IPCALAB	46,049.85	35.16	5.43	15.88	19.41

Biocon Ltd. (BIOCON) has a P/E ratio of 112.04x compared with the displayed peer median of 34.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.35% compares with a peer median of 15.88% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 55,491.09 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Biocon

• Biocon Share Price is trading near its 52-week low, keeping price action in focus.
• The stock remains below its 50 DMA of Rs 375.52 and 200 DMA of Rs 397.25.
• Biocon Fundamental Analysis shows a high P/E of 112.04 and modest ROE of 1.35%.
• The P/B ratio of 1.63 is below the same-industry median, which adds valuation context.
• Biocon Share Price Today is being tracked alongside healthcare sector benchmarks and peer comparisons.

About Biocon

Biocon Share Price reflects a company operating in Healthcare, specifically the Pharmaceuticals & Drugs industry. Biocon works across pharmaceutical research, development and commercialisation, and it is followed as a large listed healthcare name in India. The business position matters because Biocon Share Price is influenced not only by intraday sentiment but also by longer-term views on earnings, pricing power and execution in a regulated industry. The stock’s latest revenue reference in the available market data shows Rs 4,336 crore for Jun 2026, which provides a recent operating scale marker for Biocon Share Price readers.

For investors tracking Biocon Company News, the key structural point is that the company combines a meaningful market capitalisation with valuation and return metrics that need careful reading. Biocon Share Price is therefore often discussed in the same breath as Biocon Earnings, Biocon Financial Results and Biocon Stock Performance. Univest users can use Biocon Share Price Live pages to follow the company’s market position, price levels and core ratios in one place.

Track Biocon Share Price on Univest

Use Biocon Ltd. (BIOCON) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Track Biocon Share Price on Univest to review Biocon Share Price Today, key technical indicators, valuation ratios, shareholding pattern, 52-week levels and market insights in one place. Univest also helps users follow Biocon Stock News, Biocon Latest News and Biocon Share Price Update with a cleaner market snapshot.

Frequently Asked Questions

Why is Biocon Share Price near a 52-week low?

Ans. Biocon Share Price is near its 52-week low because the current market price is still well below longer-term moving averages. Univest data confirms the price event, but it does not establish a company-specific catalyst.

What is Biocon Share Price today?

Ans. Biocon Share Price today is Rs 342.25, which is up 0.51% from the previous close of Rs 340.5. The intraday range has stayed tight so far, keeping the stock near the yearly low zone.

How expensive is Biocon Share Price on earnings valuation?

Ans. Biocon Share Price has a P/E ratio of 112.04, which is above the same-industry median of 26.67 and average of 38.92. That makes the stock appear expensive on earnings multiples relative to peers.

What do Biocon ROE and ROCE show?

Ans. Biocon Share Price is backed by ROE of 1.35% and ROCE of 3.26%. Both are below the same-industry benchmark, which suggests weaker return efficiency than many healthcare peers. ROE stands at 1.35%.

What does Biocon book value mean for investors?

Ans. Biocon Share Price has a book value of Rs 208.53 per share. This shows the accounting net worth behind each share and helps investors compare the stock’s market price with asset backing.

How does Biocon Share Price compare with healthcare peers?

Ans. Biocon Share Price has a higher P/E than Abbott India, Alkem, Gland Pharma, Glenmark and Ipca in the latest Univest peer set. Its P/B is lower than all five, while profitability ratios are also weaker.

What should investors track next in Biocon Share Price?

Ans. Investors should track whether Biocon Share Price can stabilise above the recent intraday band and move closer to its moving averages. Valuation, returns and sector context remain important for Biocon Stock Analysis.